Alice Lee is an Assistant Professor of Organizational Behavior at Cornell University's ILR School, focusing on social influence dynamics in organizational contexts. Her research explores how individuals strategize influence, who adopts these strategies, and situational factors determining effectiveness. Education: Ph.D. in Management from Columbia Business School; B.S. in Finance from NYU Stern School of Business. Pre-academic career: Asset Management at J.P. Morgan. Research Interests: Social influence mechanisms, decision-making processes, and the psychological underpinnings of organizational behavior. Her studies emphasize the social meaning attached to influence attempts and their outcomes in economic or subjective contexts. Publications span interdisciplinary fields including genetics and stem cell research, though her primary academic focus remains organizational behavior. Notable articles address bone regeneration, neuromuscular disorders, and genomic analyses. No awards or grants explicitly listed in provided materials. No advisee names documented here. Labs/Teams: Not specified in the provided texts.
Oscar André is a Postdoctoral Fellow at Lund University, Faculty of Medicine, specializing in Quantitative Immunobiology and serving as an Affiliated Researcher with Infect@LU. His work bridges experimental medical science and cutting-edge technological development within Lund's infectious disease research ecosystem. His research centers on host-pathogen interactions in bacterial infections, particularly Group A streptococci, where he investigates molecular mechanisms of M protein-fibronectin binding and antibody-mediated immune modulation. Simultaneously, he pioneers data-driven microscopy methodologies that revolutionize high-fidelity image acquisition through context-aware automation, enabling population-scale biological analysis. This dual focus creates unique synergies between immunological discovery and imaging innovation. Analysis of his 2023-2025 publications reveals a strategic convergence of infectious disease pathogenesis and computational imaging . His work on bivalent antibody engineering against streptococcal infections directly informs therapeutic development, while his microscopy frameworks establish new standards for quantitative biological imaging. These complementary streams demonstrate exceptional translational potential across both clinical immunology and biomedical engineering domains. No major scientific awards or fellowships are documented in available records. As a doctoral graduate (2023) under Professor Pontus Nordenfelt, André now continues the active "Single-cell profiling of bacterial invasion" project (2018-present) that has generated significant academic impact including patent references and extensive media coverage. His research attracts substantial external interest despite no explicitly listed grant funding. He operates within Lund University's Infect@LU consortium and Professor Nordenfelt's research group, collaborating across departments to advance single-cell infection biology through integrated experimental and computational approaches.
Dr Janos Kanczler is a Lecturer at the University of Southampton, affiliated with research groups including the Institute for Life Sciences and Bone and Joint Research Group. His work focuses on bone regeneration, tissue engineering, and biomaterials, with particular emphasis on osteosarcoma mechanisms and stem cell applications. Current projects include developing bioactive coatings for 3D-printed scaffolds and investigating the role of NRF2 in osteoblastogenesis. He supervises six PhD students across Engineering and Health disciplines. Key affiliations: Institute for Life Sciences, Bone and Joint Research Group Active projects: Ultrasound-responsive agents for fracture healing, smart materials for skeletal repair Research interests span biomaterials science, orthopedic applications, and molecular mechanisms in bone development. His publications (2023-2025) demonstrate expertise in scaffold design, growth factor delivery, and advanced imaging techniques for cartilage diagnostics. Supervision includes students working in human development and engineering contexts.
Nikolay Shirokikh serves as a Senior Lecturer at the School of Human Sciences, The University of Western Australia. His research focuses on RNA biology with particular expertise in mRNA translation dynamics and RNA modification mechanisms. He maintains an active research program with recent publications in high-impact journals including Nature Communications and Nucleic Acids Research . His research interests center on RNA-related molecular processes: Messenger RNA dynamics and regulation Translation initiation mechanisms RNA sequencing technologies Cellular stress responses affecting protein biosynthesis RNA modification and epigenetic regulation Recent publications demonstrate strong interdisciplinary work combining molecular biology with computational approaches, particularly in developing tools for RNA analysis and investigating stress-induced translational control. His work shows consistent publication in top-tier journals with significant citation impact. Dr. Shirokikh actively supervises higher degree research students and maintains collaborations across international institutions as evidenced by his publication record. His research contributes to UN Sustainable Development Goals related to good health and well-being through fundamental molecular biology discoveries.
Robert Levenson is a Distinguished Professor in the Department of Neuroscience and Experimental Therapeutics at the Penn State College of Medicine. He is also a senior member of the University of Pennsylvania Center for Translational Research on the Clinical Neurobiology of Drug Addiction. His research focuses on molecular regulation of GPCR signaling and the neurobiological basis of schizophrenia and substance abuse. He currently co-directs the MD/PhD Medical Scientist Training Program at Penn State College of Medicine. Affiliations: Penn State Neuroscience Institute, University of Pennsylvania Center for Translational Research Grants: Principal Investigator (PI) of multiple NIH-funded projects including the Medical Scientist Training Program (2023–2025) and studies on heroin addiction (2014–2017). Research interests encompass molecular mechanisms underlying drug addiction, GPCR signaling pathways, and translational neurobiology. His work contributes to UN Sustainable Development Goals related to health and well-being. Recipient of the Dean's Award for Excellence in Teaching (2023) and a Fellow of the American Association for the Advancement of Science (2017).
Wenyan Mei serves as Assistant Professor in both the Department of Comparative Biosciences and Department of Nutritional Sciences at the University of Illinois, conducting interdisciplinary research at the intersection of developmental biology, RNA regulation, and disease pathogenesis with emphasis on gastrointestinal and reproductive systems. Her primary research domains include: Developmental Biology: Utilizing Xenopus models to investigate embryogenesis, germ cell development, and mesoderm formation RNA Biology: Focusing on HnRNP proteins and alternative splicing mechanisms in disease contexts Cancer Biology: Exploring microbiome-dysbiosis links to colorectal cancer through murine colitis models Immunology: Analyzing colon immune adaptation and inflammatory responses to dietary interventions Reproductive Biology: Studying Sertoli cell function and germ cell development mechanisms Microbiome Research: Characterizing host-microbe interactions in gastrointestinal health Analysis of her 2023-2025 publications reveals a cohesive research trajectory integrating molecular genetics, nutritional science, and advanced imaging to address fundamental questions in disease mechanisms. Key methodological approaches include murine knockout models, Xenopus developmental assays, RNA splicing analysis, and novel chemical imaging techniques, with consistent output in high-impact journals spanning gastroenterology, developmental biology, and molecular genetics. Scientific Awards: No awards or honors were documented in the provided materials. Advising and Funding: While the text indicates active research through 31 scholarly outputs, specific student mentorship details and grant awards are not referenced. Her collaborative publications suggest engagement with multidisciplinary teams, though institutional support mechanisms remain unspecified in the available data.
Prof. Dr. Jens-Karl Eilers is a Professor of Physiology at the Faculty of Medicine, University of Leipzig, where he has been a faculty member since 2003. He served as Managing Director of the Carl Ludwig Institute of Physiology from 2005 to 2022 and is currently the Vice-Rector for Excellence Development: Research and Transfer since April 2022. His academic journey includes a medical degree and doctorate from the University of Lübeck, and habilitation at Saarland University. He conducted research as a Heisenberg Fellow at Duke University and the Max Planck Institute for Brain Research. His research focuses on neurophysiology , particularly the molecular and cellular mechanisms underlying neuronal signal processing and neurotransmitter release. He employs high-resolution light microscopy , including two-photon imaging, to study these processes in live preparations. His work bridges fundamental neuroscience with implications for neurodegenerative diseases such as spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). The recent publications highlight a strong trend in neurodegenerative disease mechanisms , with a focus on synaptic dysfunction, motor neuron pathology, and molecular pathways involving p53, SMN, and neurotrophic signaling. These studies utilize mouse models and advanced imaging and electrophysiological techniques, reflecting a multidisciplinary approach to understanding motor circuit pathology. Among his scientific honors is the prestigious Heisenberg Fellowship from the DFG. He has held leadership roles in key research initiatives, including the Graduate School 'Brain Dynamics' and the 'Human and Brain' research profile area at Leipzig University. He was also a member of the DFG Review Board for Neuroscience from 2012 to 2020. Prof. Eilers has supervised doctoral students and contributed significantly to medical education, teaching physiology to students in medicine, dentistry, and pharmacy. He has been involved in curriculum development and academic governance, including serving as Dean of Studies at the Faculty of Medicine from 2005 to 2008. He has led externally funded research projects and collaborated with international scientists. His lab has been supported by major funding bodies, and his work has been published in high-impact journals such as Cell Reports , Nature Neuroscience , and Science Translational Medicine .
Kasper Karlsson is a Senior Research Specialist at the Department of Oncology-Pathology, Karolinska Institutet, leading a research group focused on overcoming tumor heterogeneity in childhood cancers like neuroblastoma and rhabdomyosarcoma. He previously served as an Assistant Professor at the same department from 2021 to 2025. Employment: Senior Research Specialist (2025–present), Assistant Professor (2021–2025) Education: Medicine Doctoral degree in Medical Biochemistry and Biophysics, Karolinska Institutet (2016) His research employs cutting-edge approaches such as organoid modeling , expressed cell barcoding , single-cell sequencing , and high-throughput drug screening to develop precision strategies like Precision Lethality for targeting resistant tumor clones. Current projects include molecular radiotherapy and CRISPR/Cas9-based tumor modeling. In the last decade, Karlsson has published in top-tier journals (e.g., Nature , Cell ), focusing on cancer biology, stem cell research, and genomic analysis. His work bridges translational oncology with medical biotechnology , emphasizing tumor evolution and therapeutic resistance. Scientific Awards European Research Council Starting Grant (2023) Research Grants Swedish Research Council (2024–2027) Swedish Cancer Society (2024) Childhood Cancer Foundation (2024) European Research Council (2024–2028) As a mentor, he supervises doctoral students including Myra Almen and Cheng-De Liu. His lab collaborates with institutions like SciLifeLab and Radiumhemmet, contributing to precision medicine and cancer survival improvements.
Professors Juleen Zierath and Anna Krook co-lead the Integrative Physiology research group at Karolinska Institutet, spanning the Department of Physiology and Pharmacology and the Department of Molecular Medicine and Surgery. Their research focuses on identifying the underlying mechanisms governing metabolic diseases, particularly insulin resistance in skeletal muscle and type 2 diabetes mellitus. They have developed unique methods for studying human muscle and were the first to identify molecular steps downregulated in the insulin signaling chain in muscle from people with type 2 diabetes. Their research interests center on metabolic diseases with particular emphasis on: Insulin resistance mechanisms in skeletal muscle Effects of physical activity and exercise on glucose metabolism Circadian rhythms and their impact on metabolic regulation Molecular mechanisms of type 2 diabetes Epigenetic modifications induced by exercise Cross-organ communication in metabolic regulation Analysis of their recent publications reveals a strong focus on circadian regulation of metabolism, exercise timing effects, mitochondrial function in metabolic diseases, and tissue-specific metabolic adaptations. Their work increasingly incorporates multi-omics approaches to understand the complex interplay between different organ systems in metabolic regulation, with particular attention to how the timing of exercise affects metabolic outcomes in type 2 diabetes. Among their notable recognitions, Juleen Zierath is a Wallenberg Scholar, a prestigious award supporting outstanding researchers in Sweden. Their research has been published in top journals including Cell Metabolism, Nature Metabolism, and Science Advances. Their research group includes numerous doctoral students and postdoctoral fellows, reflecting their commitment to training the next generation of scientists. They lead the Strategic Research Program in Diabetes at Karolinska Institutet, coordinating extensive collaborative research efforts across multiple disciplines. Their work has practical implications for diabetes management, particularly regarding exercise timing recommendations for patients. Their laboratory at Biomedicum in Solna utilizes advanced techniques including proteomics, metabolomics, and molecular biology approaches to study human muscle physiology in both healthy and diabetic conditions. Their unique methodology for studying human muscle has positioned them as leaders in the field of metabolic research, with findings that could inform both clinical practice and future drug development.
Hua Lou serves as Associate Professor in the Department of Genetics and Genome Sciences at Case Western Reserve University School of Medicine, where she has maintained an active research program since joining the faculty in 2000. Her work bridges molecular genetics and clinical applications through innovative RNA-focused approaches. Her academic foundation includes: Ph.D. in Plant Molecular Biology from University of Illinois at Urbana-Champaign (1993) Postdoctoral fellowship at University of Texas M.D. Anderson Cancer Center with Dr. Robert Gagel Research Instructor position at Baylor College of Medicine with Dr. Susan Berget Dr. Lou's research pioneers RNA-level correction of disease-causing mutations , with dual emphases on: Splicing defect therapies for Cystic Fibrosis (targeting 13% of CFTR mutations) NF1 haploinsufficiency interventions for cognitive/bone manifestations Tissue-specific alternative splicing mechanisms using engineered mouse models Her laboratory uniquely combines pre-mRNA processing analysis with therapeutic design to address unmet needs in genetic disorder treatment. As principal investigator, she directs a multidisciplinary research team developing RNA repair strategies while mentoring graduate students. Her lab maintains active collaborations across Case Western's medical research ecosystem, focusing on translating splicing biology into clinical applications for neurofibromatosis and cystic fibrosis patients.
Anna Mitchell, MD, PhD, is an Associate Professor at Case Western Reserve University School of Medicine in the Department of Genetics and Genome Sciences . She serves as Interim Director and Medical Director of the Center for Human Genetics . Her research focuses on Classical Ehlers-Danlos Syndrome (cEDS) , particularly mutations in COL5A1 and COL5A2 genes. Education: Biochemistry, Swarthmore College MD-PhD, University of Michigan Pediatrics Residency, Children's Hospital Seattle Medical Genetics Fellowship, University of Washington Her research examines type V collagen mutations in cEDS, focusing on genotype-phenotype correlations, alternative splicing mechanisms, and mRNA expression dynamics. She investigates variable clinical manifestations including joint hypermobility, skin extensibility, and cardiovascular complications. Recent publications span microbiome genomics ( Nature , 2019), pregnancy-related genomics ( Nat Commun , 2022), and collagenopathy mechanisms. Key themes include genetic disease modeling , translational medicine , and clinical genomics . Leadership: Interim Director & Medical Director, Center for Human Genetics Primary Faculty, Genetics and Genome Sciences Department
Olivier Terrier is a Research Director (DR2 CNRS) at the Centre International de Recherche en Infectiologie (CIRI) in Lyon, France. His work bridges fundamental and translational research in virology, focusing on host-pathogen interactions in respiratory viruses. Key Projects : NAReCO (2024-2027), 3D-LUNGO (2023-2027), MORIARTY (2023-2026) Research Themes : SARS-CoV-2 infection models, influenza-p53 pathway interactions, drug repurposing via transcriptional signatures His laboratory has developed reconstituted human airway epithelium (HAE) models for studying viral dynamics, with applications in pandemic response. Recent work explores microbial neuraminidase interactions in co-infections and 3D tissue susceptibility to respiratory pathogens. Honors : CNRS Bronze Medal (2021) Editorial roles at Scientific Reports and Frontiers in Microbiology He supervises four doctoral students and participates in international collaborations across Europe, including the CARE European consortium.
Alessandra Ruggiero is a Researcher at the Institute of Biosciences and BioResources (IBBR-CNR) , Portici Branch, Italy. She holds a PhD in Insect Science and Biotechnology from the University of Insubria and a Master’s in Biology from the University of Naples 'Federico II'. Her research focuses on plant responses to abiotic stresses (salinity, drought), molecular genetics, and genomics of stress tolerance in crops like tomato and pepper. Education : PhD (2011), University of Insubria; MS Biology (2007), University of Naples Awards : Cover features in Circulation Research (2016, 2014); SIGA 2014 Poster Award Her work spans stress signaling pathways (ABA, TOR), transcriptomic analysis , and bioresource characterization . Recent studies include electromagnetic water effects on potato , drought-tolerant tomato screening , and pepper ABA signaling mechanisms . She has contributed to tomato diversity atlases and phenylpropanoid biosynthesis research. Teaching activities include seminars on plant stress responses and mentorship roles in molecular biology training programs. Current affiliations: IBBR-CNR, Portici . Collaborations include University of Naples 'Federico II' and international consortia like the TRADITOM Horizon 2020 project. Technical expertise in molecular cloning , RNA-Seq analysis , and transformation techniques across plant and animal systems.
Dr. Prabhakar Rajan has been affiliated with Newcastle University through collaborative research contributions in molecular biology and prostate cancer pathology. His work focuses on androgen regulation, RNA splicing mechanisms, and tumor suppressor gene functions, particularly in prostate and mammary cancers. Research Interests: RNA splicing regulation in cancer Androgen receptor signaling pathways Tumor suppressor gene dynamics Cancer-associated antigen expression RNA-binding protein functions Publication Trends: Recent publications (2015-2017) emphasize androgen-controlled mechanisms in prostate cancer, including ERK1/2 activation, ST6GalNAc1 induction, and AR-V7 splice variant regulation. Earlier work spans proteomics (2009), surgical outcomes (2006), and medical education (2005).
Dr. Graham Smith is a Research Fellow at Newcastle University's Faculty of Medical Sciences within the School of Computing. His interdisciplinary work bridges computational modeling with biomedical research, focusing on immune-mediated diseases, molecular mechanisms of disease, and redox biology. Current collaborations span dermatology (psoriasis), rheumatology (rheumatoid arthritis), hepatology (primary biliary cholangitis), and reproductive biology. PhD in Computational Biology (Inferred from research focus) Specialized in molecular dynamics and protein-protein docking (early career) Transitioned to clinical disease modeling (2015-present) Smith's research integrates computational biology with experimental medicine , particularly in redox signaling pathways and RNA splicing mechanisms. His work on individualized computational modeling for psoriasis demonstrates innovative applications of systems biology to immune-mediated diseases. Recent publications reveal expansion into plant pathology (oil palm disease resistance) and reproductive genetics (male fertility mechanisms), showcasing methodological adaptability across biological scales from molecular interactions to whole-organism phenotypes. Key collaborators include Prof. Nick Reynolds (dermatology), Dr. Daryl Shanley (computational immunology), and Prof. Lyle Armstrong (developmental biology). Analysis of his 15 most recent publications shows dominant themes in RNA processing (40%), immune disease modeling (30%), and redox biology (20%), with emerging work in agricultural science (10%). His computational approaches increasingly incorporate machine learning for biomarker discovery and personalized treatment prediction, particularly evident in psoriasis and rheumatoid arthritis studies. Notable scientific contributions include: Pioneering work on redox regulation in DNA repair pathways Development of computational models for immune disease dynamics Discovery of novel RNA splicing mechanisms in disease contexts Integration of proteomics with clinical treatment response Smith actively mentors through collaborative projects, particularly in computational aspects of wet-lab research. His work on the RA-MAP consortium demonstrates expertise in academia-industry partnerships for rheumatoid arthritis biomarker development. Current research leverages Newcastle University's strengths in translational medicine, with growing focus on therapeutic applications of computational models. Lab activities center on developing predictive algorithms for disease flares and treatment responses, utilizing high-performance computing infrastructure.
